ArticleFrontiers in nutrition2025
Dietary sodium intake and all-cause mortality in rheumatoid arthritis: an NHANES analysis (2003-2018).
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pathogenic Drivers of Difficult-to-Treat Rheumatoid Arthritis: Synovium and Beyond.International journal of molecular sciences · 2026Review
- Association of a data-driven nutrient risk score with incident rheumatoid arthritis in UK Biobank adults: a prospective cohort study.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the field of nutritional epidemiology, the association between sodium intake and all-cause mortality in patients with rheumatoid arthritis (RA) remains inadequately explored. Consequently, the impact of sodium consumption on the prognosis of RA patients is not clearly defined, which leaves clinicians without adequate data to guide dietary sodium recommendations. Objectives: This study seeks to examine the potential relationship between sodium intake in the diets of patients with RA and all-cause mortality. Methods: A prospective cohort study analyzed 2,856 patients aged 20 and older with RA who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2018. Comprehensive data on mortality, dietary sodium intake, and relevant confounding variables were systematically collected. Cox regression and restricted Cubic Splines (RCS) were employed to explore the potential associations. Results: After adjusting for confounding factors, a significant inverse correlation was observed between dietary sodium intake and the risk of all-cause mortality in patients with RA. When sodium intake was treated as a continuous variable, the hazard ratio (HR) was 0.68 (95% CI: 0.56-0.81, Conclusion: The findings of this study demonstrate a negative correlation between increased dietary sodium intake and all-cause mortality risk in patients with RA within a specific range. The threshold analysis identified a breakpoint at a sodium intake of 3.1 g per day, which is equivalent to approximately 7.9 grams of salt, exceeding the World Health Organization (WHO) recommendation of 5 grams of salt per day. These findings challenge the prevailing notion that higher sodium intake is always detrimental. This may offer valuable insights for developing dietary guidelines for RA patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.